Epidemiology and Health Care Cost of Diabetic Foot Problems

@inproceedings{Cook2012EpidemiologyAH,
  title={Epidemiology and Health Care Cost of Diabetic Foot Problems},
  author={Jeremy J. Cook and Donald C. Simonson},
  year={2012}
}
In 1992, Zimmet first referred to the “epidemic of diabetes,” noting that its costs both in terms of economic burden and human suffering are rising at an alarming rate (Zimmet, Diabetes Care. 1992;15(2):232–52). The global prevalence of diabetes mellitus has been projected to nearly double from a baseline of 2.8% in 2000 to 4.4% by 2030, affecting over 350 million individuals (Wild et al. Diabetes Care. 2004;27(5):1047–53). In the decade beginning in 1997, the prevalence of diabetes in the USA… 
The cost of illness attributable to diabetic foot and cost-effectiveness of secondary prevention in Peru
TLDR
Diabetic foot complications are highly costly and largely preventable in Peru, and the implementation of a standard care strategy would lead to net savings and avert deaths over a one-year period.
Intensive versus conventional glycaemic control for treating diabetic foot ulcers.
TLDR
A review of published, unpublished, ongoing, ongoing and terminated clinical trials to assess the effects of intensive glycaemic control compared to conventional control on the outcome of foot ulcers in people with type 1 and type 2 diabetes failed to find any completed randomised clinical trials with results.
Prevalence and healthcare costs associated with the management of diabetic foot ulcer in patients attending Ahmadu Bello University Teaching Hospital, Nigeria.
TLDR
The prevalence of DFU in DM patients attending ABUTH was high and healthcare costs associated with DFU especially cost of drugs procurement contributed the highest financial burden in managing DFU.
Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers
TLDR
It is suggested that use of BLCC and HFDS for treatment of DFU may lower overall medical costs through reduced utilization of costly healthcare services.
The relationship between self-efficacy and diabetic foot self-care
Health education programmes to improve foot self-care practices and foot problems among older people with diabetes: a systematic review.
TLDR
The claim that a health education programme increases the foot self-care scores and reduces the foot problems is supported, however, there were certain methodological concerns in the reviewed articles, indicating the need for further evaluation.
Diabetes, Obesity and Nutrition Strategic Clinical Network
KEY POINTS The prevalence of diabetes in Alberta is projected to more than double from 2011 to 2035 to about 11%,[1][1] with rural and First Nations communities having even higher rates. This is
Analysis of the Peri-Operative Cost of Non-Traumatic Major Lower Extremity Amputation in Jordan
TLDR
Delayed amputations and prolonged LOS remain the most important determinants for the peri-operative cost of NMLEA.
...
1
2
3
...

References

SHOWING 1-10 OF 124 REFERENCES
Patient-Level Estimates of the Cost of Complications in Diabetes in a Managed-Care Population
TLDR
The high incidences and costs may support the value of aggressive early intervention for patients with diabetes, and will be useful for pharmacoeconomic modelling of the cost effectiveness of new and existing therapies for this condition.
A Review of the Eurodiale Studies: What Lessons for Diabetic Foot Care?
TLDR
The Eurodiale (European Study Group on Diabetes and the Lower Extremity) study was a prospective observational study conducted in 14 European centers in 2003 to 2004 and included data on characteristics of diabetic patients with foot ulcers, diagnostic and management procedures, health care organization, quality of life, and resource use.
Health-economic consequences of diabetic foot lesions.
TLDR
Prevention of foot ulcers and amputations by various methods, including patient education, proper footwear, and foot care, in patients at risk is cost effective or even cost saving.
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort
TLDR
Two thirds of diabetic patients have objective evidence for some variety of neuropathy, but only about 20% have symptoms, and only 6% of IDDM and only 1% of NIDDM patients have sufficiently severe polyneuropathy to be graded stage 2b, and none were graded stage 3.
Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis.
TLDR
Management of the diabetic foot according to guideline-based care improves survival, reduces diabetic foot complications, and is cost-effective and even cost saving compared with standard care.
Incidence, outcomes, and cost of foot ulcers in patients with diabetes.
TLDR
The results appear to support the value of foot-ulcer prevention programs for patients with diabetes and the attributable cost of care compared with that in patients without foot ulcers.
Quality of Ambulatory Care for Diabetes and Lower-Extremity Amputation
  • C. Schade, Karen L. Hannah
  • Medicine
    American journal of medical quality : the official journal of the American College of Medical Quality
  • 2007
TLDR
A claims-based case-control study of 409 Medicare beneficiaries younger than age 75 with diabetes and LEA found that LEA patients were less likely to have had lipid screening than controls, and controls were more likely to use physicians with high performance in lipid screening and hemoglobin A1c testing.
Preventing foot ulcers in patients with diabetes.
TLDR
Substantial evidence supports screening all patients with diabetes to identify those at risk for foot ulceration and recommending certain prophylactic interventions, including patient education, prescription footwear, intensive podiatric care, and evaluation for surgical interventions.
...
1
2
3
4
5
...